精神病和利苏里德的作用

New insights into the cause of Parkinson's disease.

Neurology·1992

The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Journal of neurology, neurosurgery, and psychiatry·1992

Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Brain : a journal of neurology·1992

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.

Annals of neurology·1992

"Isolated" postinfectious myoclonus.

Journal of neurology, neurosurgery, and psychiatry·1992

Striatal neuropeptide levels in Parkinson's disease patients.

Neuroscience letters·1992

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Journal of nephrology·2026

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

International journal of clinical pharmacy·2026

Pharmacists in OPAT: a systematic review and meta-analysis.

The Journal of antimicrobial chemotherapy·2026

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Healthcare (Basel, Switzerland)·2026

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

PloS one·2026

相关实验视频

精神病和利苏里德的作用

相关概念视频

New insights into the cause of Parkinson's disease.

The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.

"Isolated" postinfectious myoclonus.

Striatal neuropeptide levels in Parkinson's disease patients.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Medication-related problems in a nephrology outpatient clinic: the role of polypharmacy and computerized prescribing system performance in a resource-limited setting.

Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.

Pharmacists in OPAT: a systematic review and meta-analysis.

Willingness to Pay for Pharmacist-Led Weight Management Services in Community Pharmacies: A Cross-Sectional Study in an Academic Medical Center in Saudi Arabia.

Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.

Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.

相关实验视频

精神病和利苏里德的作用

相关概念视频

相关文章